Mutual of America Capital Management LLC Purchases New Position in Ralliant Corporation $RAL

Mutual of America Capital Management LLC acquired a new stake in shares of Ralliant Corporation (NYSE:RAL) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 12,629 shares of the company’s stock, valued at approximately $552,000.

Several other hedge funds also recently bought and sold shares of RAL. Westfuller Advisors LLC acquired a new position in shares of Ralliant in the 3rd quarter valued at $26,000. Manchester Capital Management LLC bought a new position in Ralliant during the second quarter worth about $29,000. Webster Bank N. A. acquired a new position in Ralliant in the third quarter valued at about $31,000. Evermay Wealth Management LLC bought a new stake in shares of Ralliant in the second quarter worth about $32,000. Finally, Wilmington Savings Fund Society FSB acquired a new stake in shares of Ralliant during the third quarter worth about $34,000.

Ralliant Price Performance

NYSE RAL opened at $54.62 on Wednesday. The company has a quick ratio of 1.03, a current ratio of 1.49 and a debt-to-equity ratio of 0.39. Ralliant Corporation has a 12-month low of $40.70 and a 12-month high of $55.25. The company has a market capitalization of $6.16 billion and a PE ratio of 43.01. The firm’s 50 day moving average is $51.78 and its 200-day moving average is $46.76.

Ralliant (NYSE:RAL) last released its earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.02. The business had revenue of $529.10 million during the quarter, compared to the consensus estimate of $519.14 million.

Ralliant Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, March 9th. Ralliant’s dividend payout ratio is currently 15.75%.

Analysts Set New Price Targets

Several brokerages recently issued reports on RAL. Weiss Ratings reiterated a “hold (c)” rating on shares of Ralliant in a research report on Monday, December 29th. Truist Financial started coverage on shares of Ralliant in a research note on Friday, December 12th. They issued a “buy” rating and a $62.00 price target on the stock. Royal Bank Of Canada increased their price objective on shares of Ralliant from $45.00 to $52.00 and gave the stock a “sector perform” rating in a research report on Friday, November 7th. Oppenheimer raised their price objective on shares of Ralliant from $55.00 to $60.00 and gave the stock an “outperform” rating in a report on Monday, December 15th. Finally, Barclays boosted their price objective on shares of Ralliant from $59.00 to $60.00 and gave the company an “overweight” rating in a research report on Wednesday, January 7th. Six research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $58.00.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.